Viewing Study NCT05705492


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2025-12-29 @ 4:01 PM
Study NCT ID: NCT05705492
Status: RECRUITING
Last Update Posted: 2025-04-06
First Post: 2023-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
Sponsor: OHSU Knight Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module